Status:
COMPLETED
Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Normal Population
Lead Sponsor:
GeNeuro Innovation SAS
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-60 years
Brief Summary
This study intends to explore the levels of MSRV expression by analyzing the levels of MSRV transcripts in blood, as well as the levels of the MSRV-Env protein in serum in the normal population. This ...
Eligibility Criteria
Inclusion
- Signature of an informed consent;
- Male or female between 18 and 60 years of age.
Exclusion
- Positive serology for hepatitis B or C or HIV;
- Acute infection at inclusion;
- Severe psychiatric disorder, neurological, inflammatory, or autoimmune disease;
- Pregnancy or breastfeeding;
- Heavy smokers i.e. more than 10 cigarettes per day;
- History of alcohol or drug abuse in the last 3 years;
- Participation in a clinical trial (within the last 3 months).
Key Trial Info
Start Date :
October 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT01804660
Start Date
October 1 2012
End Date
December 1 2013
Last Update
October 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Etablissement Français du Sang Rhône Alpes - 1 route de Taninges
Annemasse, France, 74100